| |
| |
|
| Insider
Information: |
Mckinnell Henry A |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
3,072,534 |
|
|
Indirect Shares
|
253,582 |
|
|
| Direct
Value |
$108,322,857 |
|
|
|
Indirect Value
|
$7,506,027 |
|
|
| Total
Shares |
3,326,116 |
|
|
| Total
Value |
$115,828,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Moodys Corp |
MCO |
Director |
2021-03-18 |
89,488 |
2003-09-25 |
0 |
Premium* |
|
|
Pfizer Inc |
PFE |
Director |
2007-02-28 |
2,134,851 |
2007-02-28 |
253,582 |
Premium* |
|
|
Exxon Mobil Corp |
XOM |
Director |
2007-01-03 |
36,400 |
2004-05-26 |
0 |
Premium* |
|
|
Angiotech Pharmaceuticals Inc(USA) |
ANPIQ |
Director |
2008-05-12 |
50,000 |
|
0 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
CEO and Chairman of th... |
2013-10-24 |
0 |
|
0 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Director |
2019-01-02 |
689,046 |
2016-08-22 |
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-05-20 |
72,749 |
2016-11-03 |
0 |
Premium* |
|
|
Federal Street Acquisition Corp |
FSAC |
Director |
2019-01-04 |
0 |
2019-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2004-02-25 |
4 |
D |
$37.20 |
$584,970 |
D/D |
(15,725) |
1,149,087 |
|
- |
|
| PFE |
Pfizer Inc |
Director |
– • – |
2007-02-28 |
4 |
D |
$24.96 |
$881,313 |
D/D |
(35,309) |
2,134,851 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and Chairman of the Board |
• • – |
2013-10-24 |
4 |
D |
$10.75 |
$268,750 |
D/D |
(25,000) |
0 |
0 |
- |
|
| FSAC |
Federal Street Acquisitio... |
Director |
– • – |
2019-01-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(25,000) |
0 |
0 |
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2003-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,250 |
1,097,198 |
|
- |
|
| PFE |
Pfizer Inc |
officerTitle |
• • – |
2005-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,400 |
1,508,996 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman of the Board |
– • – |
2006-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,030 |
1,944,258 |
0 |
- |
|
| PFE |
Pfizer Inc |
Chairman of the Board |
– • – |
2006-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,330 |
1,933,928 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2016-08-05 |
5 |
GD |
$0.00 |
$0 |
D/D |
40,436 |
80,600 |
0 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
Director |
– • – |
2008-05-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2011-01-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2005-08-16 |
4 |
OE |
$8.17 |
$2,841,199 |
D/D |
347,760 |
1,888,034 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman of the Board |
– • – |
2006-08-02 |
4 |
OE |
$12.42 |
$4,371,194 |
D/D |
351,948 |
2,220,066 |
0 |
- |
|
| PFE |
Pfizer Inc |
Director |
– • – |
2007-01-29 |
4 |
OE |
$18.35 |
$99,971 |
D/D |
5,448 |
1,971,152 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2007-10-30 |
4 |
OE |
$10.74 |
$68,280 |
D/D |
6,360 |
30,327 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2008-11-06 |
4 |
OE |
$11.06 |
$66,373 |
D/D |
6,000 |
39,501 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2009-09-29 |
4 |
OE |
$10.99 |
$109,916 |
D/D |
10,000 |
54,361 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2010-05-21 |
4 |
OE |
$14.06 |
$303,750 |
D/D |
21,600 |
80,433 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2011-11-17 |
4 |
OE |
$19.99 |
$287,820 |
D/D |
14,400 |
100,196 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2019-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,421 |
52,639 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,726 |
72,749 |
0 |
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2005-08-16 |
4 |
S |
$26.11 |
$8,035,614 |
D/D |
(307,760) |
1,580,274 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman of the Board |
– • – |
2006-08-02 |
4 |
S |
$26.19 |
$6,416,550 |
D/D |
(245,000) |
1,975,066 |
0 |
- |
|
148 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
